# Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer

> **NCT06916637** · — · RECRUITING · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 40 (estimated)

## Conditions studied

- Breast Cancer
- Breast Cancer, HER2-Expression

## Interventions

- **RADIATION:** 18F-HER2 Affibody PET scan

## Key facts

- **NCT ID:** NCT06916637
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-09
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06916637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06916637, "Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06916637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*